The global Recombinant Human Follicle-stimulating Hormone market was valued at US$ 1045.6 million in 2023 and is anticipated to reach US$ 1523 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

Recombinant Human Follicle-stimulating Hormone Market

Recombinant Human Follicle-Stimulating Hormone (r-hFSH) is a biotechnologically produced hormone that plays a crucial role in the human reproductive system. It is a synthetic form of the naturally occurring follicle-stimulating hormone (FSH), which is produced by the anterior pituitary gland in the brain. FSH is essential for the regulation of the female and male reproductive systems and is involved in processes like ovarian follicle development, sperm production, and the maturation of reproductive cells.

Increasing Demand for Assisted Reproductive Technologies (ART): The growing acceptance of ART, including in vitro fertilization (IVF), is driving the demand for r-hFSH. ART is used by individuals and couples to address infertility issues, and r-hFSH plays a vital role in controlled ovarian stimulation.

Advancements in ART Procedures: Ongoing advancements in ART procedures are leading to increased use of r-hFSH. These procedures continue to improve success rates, which further fuels demand.

Expanded Indications: The use of r-hFSH is being explored for a broader range of indications, including for individuals with specific hormonal imbalances or other medical conditions that affect reproductive health.

Personalized Medicine: Tailoring treatment regimens to individual patients is gaining importance. Clinicians are increasingly using r-hFSH in personalized fertility treatment plans, optimizing the chances of success while minimizing side effects.

Global Expansion: The use of r-hFSH is expanding globally as countries invest in reproductive healthcare infrastructure. Emerging markets are showing increased demand for fertility treatments and related products.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Follicle-stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Follicle-stimulating Hormone.

Report Scope

The Recombinant Human Follicle-stimulating Hormone market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Follicle-stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Follicle-stimulating Hormone companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Human Follicle-stimulating Hormone Market Report

Report Metric	Details
Report Name	Recombinant Human Follicle-stimulating Hormone Market
Accounted market size in 2023	US$ 1045.6 million
Forecasted market size in 2030	US$ 1523 million
CAGR	5.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	75IU 150IU Others
Segment by Application	Infertility Treatment Assisted Reproductive Technology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human Follicle-stimulating Hormone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Follicle-stimulating Hormone Market growing?

Ans: The Recombinant Human Follicle-stimulating Hormone Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Recombinant Human Follicle-stimulating Hormone Market size in 2030?

Ans: The Recombinant Human Follicle-stimulating Hormone Market size in 2030 will be US$ 1523 million.

Who are the main players in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The main players in the Recombinant Human Follicle-stimulating Hormone Market are Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical

What are the Application segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The Applications covered in the Recombinant Human Follicle-stimulating Hormone Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

Ans: The Types covered in the Recombinant Human Follicle-stimulating Hormone Market report are 75IU, 150IU, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 75IU

1.2.3 150IU

1.2.4 Others

1.3 Market by Application

1.3.1 Global Recombinant Human Follicle-stimulating Hormone Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Infertility Treatment

1.3.3 Assisted Reproductive Technology

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant Human Follicle-stimulating Hormone Market Perspective (2019-2030)

2.2 Recombinant Human Follicle-stimulating Hormone Growth Trends by Region

2.2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Recombinant Human Follicle-stimulating Hormone Historic Market Size by Region (2019-2024)

2.2.3 Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2025-2030)

2.3 Recombinant Human Follicle-stimulating Hormone Market Dynamics

2.3.1 Recombinant Human Follicle-stimulating Hormone Industry Trends

2.3.2 Recombinant Human Follicle-stimulating Hormone Market Drivers

2.3.3 Recombinant Human Follicle-stimulating Hormone Market Challenges

2.3.4 Recombinant Human Follicle-stimulating Hormone Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue

3.1.1 Global Top Recombinant Human Follicle-stimulating Hormone Players by Revenue (2019-2024)

3.1.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Players (2019-2024)

3.2 Global Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Recombinant Human Follicle-stimulating Hormone Revenue

3.4 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio

3.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Follicle-stimulating Hormone Revenue in 2023

3.5 Recombinant Human Follicle-stimulating Hormone Key Players Head office and Area Served

3.6 Key Players Recombinant Human Follicle-stimulating Hormone Product Solution and Service

3.7 Date of Enter into Recombinant Human Follicle-stimulating Hormone Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Type

4.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Type (2019-2024)

4.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2025-2030)

5 Recombinant Human Follicle-stimulating Hormone Breakdown Data by Application

5.1 Global Recombinant Human Follicle-stimulating Hormone Historic Market Size by Application (2019-2024)

5.2 Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Recombinant Human Follicle-stimulating Hormone Market Size (2019-2030)

6.2 North America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024)

6.4 North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant Human Follicle-stimulating Hormone Market Size (2019-2030)

7.2 Europe Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024)

7.4 Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size (2019-2030)

8.2 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2019-2024)

8.4 Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant Human Follicle-stimulating Hormone Market Size (2019-2030)

9.2 Latin America Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024)

9.4 Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size (2019-2030)

10.2 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024)

10.4 Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Recombinant Human Follicle-stimulating Hormone Introduction

11.1.4 Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.1.5 Merck Recent Development

11.2 Ferring

11.2.1 Ferring Company Detail

11.2.2 Ferring Business Overview

11.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Introduction

11.2.4 Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.2.5 Ferring Recent Development

11.3 Livzon

11.3.1 Livzon Company Detail

11.3.2 Livzon Business Overview

11.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Introduction

11.3.4 Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.3.5 Livzon Recent Development

11.4 Gedeon Richter

11.4.1 Gedeon Richter Company Detail

11.4.2 Gedeon Richter Business Overview

11.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Introduction

11.4.4 Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.4.5 Gedeon Richter Recent Development

11.5 GenSci

11.5.1 GenSci Company Detail

11.5.2 GenSci Business Overview

11.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Introduction

11.5.4 GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.5.5 GenSci Recent Development

11.6 Teva

11.6.1 Teva Company Detail

11.6.2 Teva Business Overview

11.6.3 Teva Recombinant Human Follicle-stimulating Hormone Introduction

11.6.4 Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.6.5 Teva Recent Development

11.7 ChangChun High & New Technology

11.7.1 ChangChun High & New Technology Company Detail

11.7.2 ChangChun High & New Technology Business Overview

11.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Introduction

11.7.4 ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.7.5 ChangChun High & New Technology Recent Development

11.8 ABL

11.8.1 ABL Company Detail

11.8.2 ABL Business Overview

11.8.3 ABL Recombinant Human Follicle-stimulating Hormone Introduction

11.8.4 ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.8.5 ABL Recent Development

11.9 Scripps Laboratories

11.9.1 Scripps Laboratories Company Detail

11.9.2 Scripps Laboratories Business Overview

11.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Introduction

11.9.4 Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.9.5 Scripps Laboratories Recent Development

11.10 Alphamab Oncology

11.10.1 Alphamab Oncology Company Detail

11.10.2 Alphamab Oncology Business Overview

11.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Introduction

11.10.4 Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.10.5 Alphamab Oncology Recent Development

11.11 Hunan Jingfeng Pharmaceutical

11.11.1 Hunan Jingfeng Pharmaceutical Company Detail

11.11.2 Hunan Jingfeng Pharmaceutical Business Overview

11.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.11.4 Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.11.5 Hunan Jingfeng Pharmaceutical Recent Development

11.12 Qilu Pharmaceutical

11.12.1 Qilu Pharmaceutical Company Detail

11.12.2 Qilu Pharmaceutical Business Overview

11.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.12.4 Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.12.5 Qilu Pharmaceutical Recent Development

11.13 Beijing SL Pharmaceutical

11.13.1 Beijing SL Pharmaceutical Company Detail

11.13.2 Beijing SL Pharmaceutical Business Overview

11.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Introduction

11.13.4 Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

11.13.5 Beijing SL Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

ChangChun High & New Technology

Beijing SL Pharmaceutical

Hunan Jingfeng Pharmaceutical

List of Tables

Table 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of 75IU

Table 3. Key Players of 150IU

Table 4. Key Players of Others

Table 5. Global Recombinant Human Follicle-stimulating Hormone Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Recombinant Human Follicle-stimulating Hormone Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2019-2024)

Table 9. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region (2025-2030)

Table 11. Recombinant Human Follicle-stimulating Hormone Market Trends

Table 12. Recombinant Human Follicle-stimulating Hormone Market Drivers

Table 13. Recombinant Human Follicle-stimulating Hormone Market Challenges

Table 14. Recombinant Human Follicle-stimulating Hormone Market Restraints

Table 15. Global Recombinant Human Follicle-stimulating Hormone Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players (2019-2024)

Table 17. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2023)

Table 18. Ranking of Global Top Recombinant Human Follicle-stimulating Hormone Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Recombinant Human Follicle-stimulating Hormone Product Solution and Service

Table 22. Date of Enter into Recombinant Human Follicle-stimulating Hormone Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2019-2024)

Table 26. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Type (2025-2030)

Table 28. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2019-2024)

Table 30. Global Recombinant Human Follicle-stimulating Hormone Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Application (2025-2030)

Table 32. North America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size by Country (2025-2030) & (US$ Million)

Table 47. Merck Company Detail

Table 48. Merck Business Overview

Table 49. Merck Recombinant Human Follicle-stimulating Hormone Product

Table 50. Merck Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 51. Merck Recent Development

Table 52. Ferring Company Detail

Table 53. Ferring Business Overview

Table 54. Ferring Recombinant Human Follicle-stimulating Hormone Product

Table 55. Ferring Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 56. Ferring Recent Development

Table 57. Livzon Company Detail

Table 58. Livzon Business Overview

Table 59. Livzon Recombinant Human Follicle-stimulating Hormone Product

Table 60. Livzon Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 61. Livzon Recent Development

Table 62. Gedeon Richter Company Detail

Table 63. Gedeon Richter Business Overview

Table 64. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product

Table 65. Gedeon Richter Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 66. Gedeon Richter Recent Development

Table 67. GenSci Company Detail

Table 68. GenSci Business Overview

Table 69. GenSci Recombinant Human Follicle-stimulating Hormone Product

Table 70. GenSci Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 71. GenSci Recent Development

Table 72. Teva Company Detail

Table 73. Teva Business Overview

Table 74. Teva Recombinant Human Follicle-stimulating Hormone Product

Table 75. Teva Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 76. Teva Recent Development

Table 77. ChangChun High & New Technology Company Detail

Table 78. ChangChun High & New Technology Business Overview

Table 79. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product

Table 80. ChangChun High & New Technology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 81. ChangChun High & New Technology Recent Development

Table 82. ABL Company Detail

Table 83. ABL Business Overview

Table 84. ABL Recombinant Human Follicle-stimulating Hormone Product

Table 85. ABL Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 86. ABL Recent Development

Table 87. Scripps Laboratories Company Detail

Table 88. Scripps Laboratories Business Overview

Table 89. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product

Table 90. Scripps Laboratories Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 91. Scripps Laboratories Recent Development

Table 92. Alphamab Oncology Company Detail

Table 93. Alphamab Oncology Business Overview

Table 94. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product

Table 95. Alphamab Oncology Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 96. Alphamab Oncology Recent Development

Table 97. Hunan Jingfeng Pharmaceutical Company Detail

Table 98. Hunan Jingfeng Pharmaceutical Business Overview

Table 99. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 100. Hunan Jingfeng Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 101. Hunan Jingfeng Pharmaceutical Recent Development

Table 102. Qilu Pharmaceutical Company Detail

Table 103. Qilu Pharmaceutical Business Overview

Table 104. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 105. Qilu Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 106. Qilu Pharmaceutical Recent Development

Table 107. Beijing SL Pharmaceutical Company Detail

Table 108. Beijing SL Pharmaceutical Business Overview

Table 109. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product

Table 110. Beijing SL Pharmaceutical Revenue in Recombinant Human Follicle-stimulating Hormone Business (2019-2024) & (US$ Million)

Table 111. Beijing SL Pharmaceutical Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type: 2023 VS 2030

Figure 3. 75IU Features

Figure 4. 150IU Features

Figure 5. Others Features

Figure 6. Global Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application: 2023 VS 2030

Figure 8. Infertility Treatment Case Studies

Figure 9. Assisted Reproductive Technology Case Studies

Figure 10. Recombinant Human Follicle-stimulating Hormone Report Years Considered

Figure 11. Global Recombinant Human Follicle-stimulating Hormone Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Recombinant Human Follicle-stimulating Hormone Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Recombinant Human Follicle-stimulating Hormone Market Share by Region: 2023 VS 2030

Figure 14. Global Recombinant Human Follicle-stimulating Hormone Market Share by Players in 2023

Figure 15. Global Top Recombinant Human Follicle-stimulating Hormone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2023

Figure 17. North America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)

Figure 19. United States Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)

Figure 23. Germany Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Recombinant Human Follicle-stimulating Hormone Market Share by Region (2019-2030)

Figure 31. China Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)

Figure 39. Mexico Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Recombinant Human Follicle-stimulating Hormone Market Share by Country (2019-2030)

Figure 43. Turkey Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Merck Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 46. Ferring Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 47. Livzon Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 48. Gedeon Richter Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 49. GenSci Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 50. Teva Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 51. ChangChun High & New Technology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 52. ABL Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 53. Scripps Laboratories Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 54. Alphamab Oncology Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 55. Hunan Jingfeng Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 56. Qilu Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 57. Beijing SL Pharmaceutical Revenue Growth Rate in Recombinant Human Follicle-stimulating Hormone Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-6P8206

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Ether Solvent for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22W13490

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Clinical Trial Imaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-0Z6112

Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Smart Pills and Drugs Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5Q14261

Fri Nov 22 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-2H13721

Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2024

FEATURED COMPANIES

Recombinant Human Follicle-stimulating Hormone Market Size

Recombinant Human Follicle-stimulating Hormone Market

Report Scope

Scope of Recombinant Human Follicle-stimulating Hormone Market Report

Chapter Outline

FAQ for this report

How fast is Recombinant Human Follicle-stimulating Hormone Market growing?

What is the Recombinant Human Follicle-stimulating Hormone Market size in 2030?

Who are the main players in the Recombinant Human Follicle-stimulating Hormone Market report?

What are the Application segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

What are the Type segmentation covered in the Recombinant Human Follicle-stimulating Hormone Market report?

FEATURED COMPANIES

RELATED REPORTS